Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Glioma inhibition by HGF/NK2, an antagonist of scatter factor/hepatocyte growth factor.

Biochemical and biophysical research communications - 24 Jun 2000

Guerin C, Luddy C, Abounader R, Lal B, Laterra J

Abstract excerpt

Strategies that antagonize growth factor signaling are attractive candidates for the biological therapy of brain tumors. HGF/NK2 is a secreted truncated splicing variant and potential antagonist of scatter factor/hepatocyte growth factor (SF/HGF), a multifunctional cytokine involved in the malignant progression of solid tumors including glioblastoma. U87 human malignant glioma cells that express an autocrine...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Agar
Share to Autocrine Communication
Share to Gene Transfer Techniques

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Hepatocyte Growth Factor

Share to Mice, SCID

Share to Molecular Weight

Share to Neoplasm Transplantation

Share to Transplantation, Heterologous

Source

Identifiers

PMID: 10873600
DOI: 10.1006/bbrc.2000.2935

Genes

HGF

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Glioma inhibition by HGF/NK2, an antagonist of scatter factor/hepatocyte growth factor.PMID 10873600Read ↗

Reversion of human glioblastoma malignancy by U1 small nuclear RNA/ribozyme targeting of scatter factor/hepatocyte growth factor and c-met expression.Semantic proximity Read ↗

HGF–MET Cascade, a Key Target for Inhibiting Cancer Metastasis: The Impact of NK4 Discovery on Cancer Biology and TherapeuticsSemantic proximity Read ↗

Role of hepatocyte growth factor activator (HGF activator) in invasive growth of human glioblastoma cells in vivo.Semantic proximity Read ↗

Antagonistic effect of NK4, a novel hepatocyte growth factor variant, on in vitro angiogenesis of human vascular endothelial cells.Semantic proximity Read ↗

Neural stem cell migration toward gliomas in vitroSemantic proximity Read ↗

Neural Stem Cell Targeting of Glioma Is Dependent on Phosphoinositide 3-Kinase SignalingSemantic proximity Read ↗

Hepatocyte growth factor (HGF) autocrine activation predicts sensitivity to MET inhibition in glioblastomaSemantic proximity Read ↗

NK4, an antagonist of hepatocyte growth factor (HGF), inhibits growth of multiple myeloma cells: molecular targeting of angiogenic growth factorSemantic proximity Read ↗

HGF/scatter factor selectively promotes cell invasion by increasing integrin avidity.Semantic proximity Read ↗

Autocrine hepatocyte growth factor/scatter factor-Met signaling induces transformation and the invasive/metastastic phenotype in C127 cells.Semantic proximity Read ↗

Reduced HGF expression in subcutaneous CT26 tumor genetically modified to secrete NK4 and its possible relation with antitumor effects.Semantic proximity Read ↗

Structural basis for agonism and antagonism of hepatocyte growth factor.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.